55 results
424B5
XENE
Xenon Pharmaceuticals Inc
30 Nov 23
Prospectus supplement for primary offering
4:18pm
of delaying, deferring or discouraging another party from acquiring control of our company by means of a tender offer, a proxy contest or otherwise
424B5
XENE
Xenon Pharmaceuticals Inc
29 Nov 23
Prospectus supplement for primary offering
5:05pm
of a tender offer, a proxy contest or otherwise, or may affect the price an acquiring party would be willing to offer in such an instance. The material
424B5
6pul cukjjnr
23 Jun 22
Prospectus supplement for primary offering
4:09pm
424B5
iqzg3y0cx
22 Jun 22
Prospectus supplement for primary offering
4:05pm
424B5
se6 1zd16v07
1 Mar 22
Prospectus supplement for primary offering
5:12pm
424B5
dpuvb2c6a0d0f mz
6 Oct 21
Prospectus supplement for primary offering
5:05pm
424B5
74zp8bubz8 1qbrqcs6
4 Oct 21
Prospectus supplement for primary offering
5:27pm
424B5
qg7ooa3um7l
9 Mar 21
Prospectus supplement for primary offering
5:26pm